- Lobbying
- Lobbying by Acambis, Inc. U.S.
Lobbying Relationship
Bills mentioned
S.2564: Biodefense and Pandemic Vaccine and Drug Development Act of 2006
Sponsor: Richard M. Burr (R-N.C.)
S.1873: Biodefense and Pandemic Vaccine and Drug Development Act of 2005
Sponsor: Richard M. Burr (R-N.C.)
S.3: Protecting America in the War on Terror Act of 2005
Sponsor: Judd Gregg (R-N.H.)
S.975: Project BioShield II Act of 2005
Sponsor: Joseph I. Lieberman (I-Conn.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Donald "Dack" Dalrymple | Principal and Managing Director |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate